DK613889A - Farmaceutisk praeparat indeholdende 1-isobutyl-1h-imidazo(4,5-c)quinolin-4-amin - Google Patents

Farmaceutisk praeparat indeholdende 1-isobutyl-1h-imidazo(4,5-c)quinolin-4-amin Download PDF

Info

Publication number
DK613889A
DK613889A DK613889A DK613889A DK613889A DK 613889 A DK613889 A DK 613889A DK 613889 A DK613889 A DK 613889A DK 613889 A DK613889 A DK 613889A DK 613889 A DK613889 A DK 613889A
Authority
DK
Denmark
Prior art keywords
quinolin
imidazo
isobutyl
amine
pharmaceutical preparation
Prior art date
Application number
DK613889A
Other languages
English (en)
Other versions
DK613889D0 (da
DK176121B1 (da
Inventor
Steven Marshall Wick
Helen Jensen Schultz
Gregory Roy Nelson
Amit Kumar Mitra
Stephen Michael Berge
Original Assignee
Riker Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Riker Laboratories Inc filed Critical Riker Laboratories Inc
Publication of DK613889D0 publication Critical patent/DK613889D0/da
Publication of DK613889A publication Critical patent/DK613889A/da
Application granted granted Critical
Publication of DK176121B1 publication Critical patent/DK176121B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK198906138A 1988-12-15 1989-12-06 Farmaceutisk præparat indeholdende 1-isobutyl-1H-imidazol[4,5-c]-quinolin-4-amin DK176121B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28493388A 1988-12-15 1988-12-15
US28493388 1988-12-15

Publications (3)

Publication Number Publication Date
DK613889D0 DK613889D0 (da) 1989-12-06
DK613889A true DK613889A (da) 1990-06-16
DK176121B1 DK176121B1 (da) 2006-09-11

Family

ID=23092090

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198906138A DK176121B1 (da) 1988-12-15 1989-12-06 Farmaceutisk præparat indeholdende 1-isobutyl-1H-imidazol[4,5-c]-quinolin-4-amin

Country Status (14)

Country Link
EP (1) EP0376534B1 (da)
JP (1) JP2915034B2 (da)
KR (1) KR0150445B1 (da)
AU (1) AU631585B2 (da)
CA (1) CA2004597C (da)
DE (2) DE19975026I2 (da)
DK (1) DK176121B1 (da)
ES (1) ES2062043T3 (da)
HK (1) HK1006275A1 (da)
IE (1) IE62569B1 (da)
IL (1) IL92537A (da)
NL (1) NL980042I1 (da)
NZ (1) NZ231655A (da)
ZA (1) ZA899450B (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ232740A (en) * 1989-04-20 1992-06-25 Riker Laboratories Inc Solution for parenteral administration comprising a 1h-imidazo(4,5-c) quinolin-4-amine derivative, an acid and a tonicity adjuster
IL105325A (en) * 1992-04-16 1996-11-14 Minnesota Mining & Mfg Immunogen/vaccine adjuvant composition
US5747069A (en) * 1993-08-10 1998-05-05 Fujisawa Pharmaceutical Co., Ltd. Percutaneously absorbable preparation
DE4434775A1 (de) * 1994-09-29 1996-04-04 Beiersdorf Ag Dermatologische Zubereitungen mit einem Gehalt an Fettsäureglyceriden gegen Superinfektionen
US5939090A (en) * 1996-12-03 1999-08-17 3M Innovative Properties Company Gel formulations for topical drug delivery
IT1294748B1 (it) * 1997-09-17 1999-04-12 Permatec Tech Ag Formulazione per un dispositivo transdermico
NZ512628A (en) * 1999-01-08 2004-03-26 3M Innovative Properties Co Formulations and methods for treatment of mucosal associated conditions with an immune response modifier
US8119159B2 (en) 1999-02-22 2012-02-21 Merrion Research Iii Limited Solid oral dosage form containing an enhancer
US7658938B2 (en) 1999-02-22 2010-02-09 Merrion Reasearch III Limited Solid oral dosage form containing an enhancer
EP1390383B1 (en) 2001-05-11 2012-02-29 Isis Pharmaceuticals, Inc. Antisense permeation enhancers
EP1390024A4 (en) * 2001-05-11 2010-02-17 Merrion Res Iii Ltd ISOSTEARIC ACID SALTS AS PERMEATION IMPROVERS
WO2004080430A2 (en) * 2003-03-13 2004-09-23 3M Innovative Properties Company Methods of improving skin quality
CN1292751C (zh) * 2002-04-23 2007-01-03 四川大学 皮肤局部用咪喹莫特或其衍生物脂质体及其制备方法和用途
WO2007117706A2 (en) 2006-04-07 2007-10-18 Merrion Research Iii Limited Solid oral dosage form containing an enhancer
US9023863B2 (en) 2006-07-14 2015-05-05 Stiefel Research Australia Pty Ltd Fatty acid pharmaceutical foam
WO2008010963A2 (en) * 2006-07-18 2008-01-24 3M Innovative Properties Company Immune response modifier formulations
CN102046192B (zh) 2008-05-07 2014-11-19 默里昂研究Ⅲ有限公司 GnRH相关化合物的组合物及制备方法
WO2011120033A1 (en) 2010-03-26 2011-09-29 Merrion Research Iii Limited Pharmaceutical compositions of selective factor xa inhibitors for oral administration
WO2012094598A2 (en) 2011-01-07 2012-07-12 Merrion Research Iii Limited Pharmaceutical compositions of iron for oral administration
US10265384B2 (en) 2015-01-29 2019-04-23 Novo Nordisk A/S Tablets comprising GLP-1 agonist and enteric coating
ES2940736B2 (es) 2021-11-09 2023-09-19 Ntd Labs S L U Uso combinado de imiquimod y de un hidrolizado de caseina para el tratamiento de condilomas

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL73534A (en) * 1983-11-18 1990-12-23 Riker Laboratories Inc 1h-imidazo(4,5-c)quinoline-4-amines,their preparation and pharmaceutical compositions containing certain such compounds
DE3685895T2 (de) * 1985-02-25 1992-12-24 Univ Rutgers Dosierungssystem fuer transdermale absorption von arzneimittelwirkstoffen.
CA1288698C (en) * 1985-08-30 1991-09-10 Rutgers, The State University Of New Jersey Transdermal anti-anginal pharmaceutical dosage

Also Published As

Publication number Publication date
KR900009084A (ko) 1990-07-02
DE68911499D1 (de) 1994-01-27
NZ231655A (en) 1992-06-25
JPH02282327A (ja) 1990-11-19
KR0150445B1 (ko) 1998-10-15
IL92537A (en) 1994-04-12
JP2915034B2 (ja) 1999-07-05
IE62569B1 (en) 1995-02-08
CA2004597A1 (en) 1990-06-15
HK1006275A1 (en) 1999-02-19
ZA899450B (en) 1990-09-26
ES2062043T3 (es) 1994-12-16
CA2004597C (en) 2000-02-08
IL92537A0 (en) 1990-08-31
EP0376534A1 (en) 1990-07-04
DK613889D0 (da) 1989-12-06
AU631585B2 (en) 1992-12-03
NL980042I1 (nl) 1999-02-01
DE19975026I2 (de) 2010-07-08
DK176121B1 (da) 2006-09-11
IE893888L (en) 1990-06-15
DE68911499T2 (de) 1994-06-30
EP0376534B1 (en) 1993-12-15
AU4670689A (en) 1990-06-21

Similar Documents

Publication Publication Date Title
DK613889D0 (da) Farmaceutisk praeparat indeholdende 1-isobutyl-1h-imidazo(4,5-c)quinolin-4-amin
IL84522A0 (en) Imidazopyridine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
AU632099B2 (en) Olefinic 1h-imidazo (4,5-c)quinolin-4-amines
AU5005490A (en) 1h-imidazo(4,5-c)quinolin-4-amines
IT1213379B (it) Tiazolo [4,5-c]chinoline, procedimento per la loro preparazione e composizioni farmaceutiche che le contengono.
ZA876817B (en) Imidazopyridine derivatives
ES2019646B3 (es) Procedimiento de preparacion de imidazopiridinas.
AU5149690A (en) Parenteral formulation of 1-isobutyl-1H-imidazo (4,5-c) quinolin-4-amine
DK195988A (da) Farmaceutisk praeparat indeholdende mikrokapsler
DK190986A (da) Imidazoquinolinonderivater
PH24909A (en) Imidazopyridine derivatives and pharmaceutical compositions
IL87809A0 (en) Imidazopyridine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
DK314089A (da) Orale praeparater
DK489189D0 (da) Farmaceutisk praeparat
DK440587A (da) Farmaceutisk praeparat indeholdende sulindac
DK47787D0 (da) Dihydropyridinderivatholdige retardpraeparater
DK603988D0 (da) Farmaceutisk praeparat
AT389119B (de) Pyrido(3,2,1-ij)-1,3,4-benzoxadiazinderivate und diese enthaltende pharmazeutische praeparate
IL96589A0 (en) 2-substituted-imidazo-(4,5-c)pyridines,their preparation,and pharmaceutical compositions containing them
MX172943B (es) Formulacion farmaceutica
DK336489A (da) Farmaceutisk praeparat
DK273187A (da) Farmaceutiske praeparater indeholdende naphthyridinderivater
DK624587D0 (da) Farmaceutisk praeparat indeholdende imidazolderivater
DK37589D0 (da) Farmaceutisk praeparat for 4-aroylimidazol-2-oner
DK364589A (da) Pyrido(3,4-f)pyrrolo(1,2-b)(1,2,5)-triazepiner, deres fremstilling og anvendelse som laegemidler

Legal Events

Date Code Title Description
PUP Patent expired